SGK
RMD icon

Steigerwald Gordon & Koch’s ResMed RMD Stock Holding History

Steigerwald Gordon & Koch’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.74K Hold
50
– – ﹤0.01% 540
2026
Q1 		$11.2K Hold
50
– – ﹤0.01% 510
2025
Q4 		$12K Hold
50
– – ﹤0.01% 537
2025
Q3 		$13.7K Buy
+50
New +$13.7K ﹤0.01% 485

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Steigerwald Gordon & Koch's RMD Position: Q2 2026 in Review

Steigerwald Gordon & Koch held its ResMed (RMD) position steady in Q2 2026 at 50 shares worth $9.74K. The position accounts for ﹤0.01% of the portfolio, ranked #540.

Steigerwald Gordon & Koch first reported a position in RMD in Q3 2025 and has held it in 4 quarters since. The position peaked at $13.7K in Q3 2025. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Steigerwald Gordon & Koch held 50 shares of ResMed worth $9.74K as of Q2 2026.
  • Steigerwald Gordon & Koch left its ResMed share count unchanged in Q2 2026.
  • ResMed made up ﹤0.01% of Steigerwald Gordon & Koch's portfolio in Q2 2026, its #540 holding.
  • Steigerwald Gordon & Koch first reported a position in ResMed in Q3 2025 and has held it in 4 quarters since.
  • Steigerwald Gordon & Koch's ResMed position peaked at $13.7K in Q3 2025.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Steigerwald Gordon & Koch's 13F filing for Q2 2026, filed 23 Jul 2026.